Angola vs Senegal: The number of people with susceptibility test result for rifampicin
Angola
33.12
in 2021
Senegal
30.79
in 2021
Angola rank
130th
Senegal rank
132nd
The number of people with susceptibility test result for rifampicin over time
- Angola
- Senegal
How they compare
Angola currently reports 33.12 against 30.79 in Senegal, a difference of 2.33.
That makes Angola's figure about 1.1 times Senegal's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Senegal ahead.
Angola ranks 130th and Senegal ranks 132nd of 146 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Angola | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.65 | 24.99 | 3.67 | Angola |
| 2020s | 18.32 | 23.63 | 5.31 | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Senegal?
- Angola, at 33.12 against 30.79 in Senegal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Senegal?
- 2.33, with Angola ahead.
- How many years of comparable data are there for Angola and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 130th and Senegal ranks 132nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.